BioWorld

July 18, 2002

Versicor Extending Deals With Novartis, Pharmacia

Versicor Inc. said it extended a pair of unrelated deals - one with Novartis AG for antibacterials and one with Pharmacia Corp. for antibiotics. (BioWorld Today) Read More

Oncology-Focused OSI Agrees To Wind Down' Pfizer Deal

Malarial Pathogen, Plasmodium falciparum, Aced Ace Chloroquin Drug Long Ago; New Ploys Afoot

Sangamo Zinc Finger Platform To Build Cell Line For Icagen

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 12, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 12, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

Illustration of head with maze that is missing parts

CTAD 2025: The challenges of combination therapies for dementia

BioWorld Science

At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...

DEE-lightful: Praxis’ phase II results allow stock to flex its muscle

BioWorld

Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...